These 5 companies have amazing earnings surprise track records. Can they beat again? zacks.com zacks.com/ultimate
Investor Tips
Ben Rains explores the market and the overall improving earnings picture. The episode then dives into Nvidia (NVDA) and Salesforce (CRM) before they release their first quarter financial results to help investors decide if they should buy either of the tech stocks. (0:45) – Stock Market Update: Everything You Need To Know (5:20) – Breaking
A value needle in a haystack of frothy SPAC valuations
The two big pure-play stocks in the streaming TV industry are Roku (ROKU) and Netflix (NFLX). On today’s episode of Full Court Finance at Zacks, we dive into the streaming TV world as we approach a full year of empty movie theaters and a lack of most out-of-home entertainment to see which of the two
New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt.
Learn more about the Bull and Bear of the day go to https://www.zacks.com/bull
Ben Rains looks at the market’s movement and fundamentals over the last several weeks. The episode then explores two highly-ranked stocks that fit under the broader technology umbrella, Micron (MU) and Align Technology (ALGN), to see if investors might want to consider buying them on the dip amid the recent selling. (0:45) – Market Update:
A Company Well Positioned to Gain Market Share and One to Gain From E-Commerce Boom.
Stitch Fix reported some disappointing numbers for the quarter and the stock is under pressure.
Planning your tactical buys during market corrections is critical to execution and long-run success
A Financial Services and Computer Technology Company are Spotlighted
These ETFs follow the moves of retail traders
zacks.com zacks.com/ultimate
A Company in a Hot Space and a Medical Device Company with “A” Rated Momentum.
Value is outperforming growth this year
No, it’s not the end of the bull market. Hold your nose and buy some tech!
Top Picks for Investors Interested in the Shipping and Medical Space.
What stocks should you buy that blew up in the Archegos meltdown last week?
Time for the final nail in the gilded sarcophagus of the barbarous relic.
How investors with clear battle plans didn’t flinch when bargains fell into their sights in March.